•
Mar 31, 2015

Jazz Pharmaceuticals Q1 2015 Earnings Report

Total Revenue
$309M
Previous year: $247M
+25.3%
EPS
$1.99
Previous year: $1.61
+23.6%
Gross Profit
$281M
Previous year: $216M
+30.1%
Cash and Equivalents
$783M
Previous year: $246M
+218.3%
Total Assets
$3.24B
Previous year: $3.2B
+1.3%

Jazz Pharmaceuticals

Jazz Pharmaceuticals